Novasep appoints two key executives
Stephen Stefano heads up Novasep North American business and Patrick Glaser leads Novasep Synthesis division
Before joining Novasep, Stefano was Senior Vice President at GlaxoSmithKline Pharmaceuticals in charge of Business Development for North America and New Product Planning. Stefano’s career spanned 29 years from 1981-2010 at Glaxo, GlaxoWellcome and GlaxoSmithKline, where he directed the sales of most business segments including Primary Care, Specialty, Hospital, and Managed Healthcare. He had full P&L responsibility for several multi-billion dollar divisions.
Glaser held senior management, strategic marketing and strategic business development positions successively at Knoll Pharmaceuticals (1986-1998), BASF Corporation (1998-2005) and Dr Reddy’s Laboratories (2005-2009), where he was Vice President of its active pharmaceutical ingredient business, and recently in charge of a strategic contract manufacturing acquisition and integration. Born in Austria, Patrick has spent 25 years in the USA, and masters both European and US business environments.
Novasep expects both to play an important role in its development plans over the next few years. The US will be a major source of growth for both Novasep Process and Novasep Synthesis divisions, while the group’s activity in synthetic molecule manufacture will remain globally its largest source of revenues.
These appointments follow last year’s hiring of Antoine Baule as president of the Novasep Process division, and the subsequent acquisition of the biopharmaceutical CMO Henogen, key milestones in the group’s strong expansion in biopharmaceutical manufacturing.
Most read news
Organizations
Other news from the department people
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.